Connection

Peisheng Xu to Mice

This is a "connection" page, showing publications Peisheng Xu has written about Mice.
Connection Strength

0.464
  1. Carrier-Free Nanoassembly of Curcumin-Erlotinib Conjugate for Cancer Targeted Therapy. Adv Healthc Mater. 2020 10; 9(19):e2001128.
    View in: PubMed
    Score: 0.077
  2. A bioactivatable self-quenched nanogel for targeted photodynamic therapy. Biomater Sci. 2019 Dec 01; 7(12):5143-5149.
    View in: PubMed
    Score: 0.072
  3. Repurposing suramin for the treatment of breast cancer lung metastasis with glycol chitosan-based nanoparticles. Acta Biomater. 2019 01 15; 84:378-390.
    View in: PubMed
    Score: 0.068
  4. Repurposing disulfiram for cancer therapy via targeted nanotechnology through enhanced tumor mass penetration and disassembly. Acta Biomater. 2018 03 01; 68:113-124.
    View in: PubMed
    Score: 0.064
  5. Redox Potential-Sensitive N-Acetyl Cysteine-Prodrug Nanoparticles Inhibit the Activation of Microglia and Improve Neuronal Survival. Mol Pharm. 2017 05 01; 14(5):1591-1600.
    View in: PubMed
    Score: 0.060
  6. Triple-responsive expansile nanogel for tumor and mitochondria targeted photosensitizer delivery. Biomaterials. 2014 Nov; 35(35):9546-53.
    View in: PubMed
    Score: 0.050
  7. Design of serum compatible tetrary complexes for gene delivery. Macromol Biosci. 2012 May; 12(5):637-46.
    View in: PubMed
    Score: 0.043
  8. Autophagy, Cell Viability, and Chemoresistance Are Regulated By miR-489 in Breast Cancer. Mol Cancer Res. 2018 09; 16(9):1348-1360.
    View in: PubMed
    Score: 0.016
  9. A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth. Oncotarget. 2016 Apr 05; 7(14):18295-308.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.